Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$55.6 - $77.89 $556,000 - $778,900
10,000 New
10,000 $620,000
Q2 2022

Aug 15, 2022

SELL
$55.54 - $72.65 $982,613 - $1.29 Million
-17,692 Reduced 17.69%
82,308 $5.44 Million
Q1 2022

May 16, 2022

BUY
$24.28 - $56.64 $2.43 Million - $5.66 Million
100,000 New
100,000 $5.53 Million
Q3 2021

Nov 15, 2021

SELL
$24.23 - $28.59 $726,900 - $857,700
-30,000 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$19.51 - $27.64 $585,300 - $829,200
30,000 New
30,000 $829,000

Others Institutions Holding LNTH

About Lantheus Holdings, Inc.


  • Ticker LNTH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 68,741,904
  • Market Cap $6.08B
  • Description
  • Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...
More about LNTH
Track This Portfolio

Track Cinctive Capital Management LP Portfolio

Follow Cinctive Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cinctive Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Cinctive Capital Management LP with notifications on news.